1.Vengelen-Tyler V, editor. Technical manual. 12th ed.Bethesda: American Association of Blood Bank;1996. p. 349–78.
2.Han KS, Park MH, editors. Tranfusion medicine. 3rd ed.Seoul: Korea Medical Book Publisher Co;2006. p. 279. (한규섭, 박명희 등. 수혈의학. 제3판. 서울: 고려의학 2006 279).
3.Kim MH., Suh JT., Lee WI. The frequency of unexpected antibodies in transfusion candidates in recent 6 years. Korean J Blood Transfus. 2004. 15:162–7. (김명희, 서진태, 이우인. 최근 6년간 수혈대상환자에서동정된비예기항체의빈도. 대한수혈학회지 2004;15: 162-7.).
4.Oh DJ., Kim MJ., Seo DH., Song EY., Han KS., Kim HO. The frequency of unexpected antibodies in blood donors and transfusion candidates in Korea. Korean J Blood Transfus. 2003. 14:160–72. (오덕자, 김문정, 서동희, 송은영, 한규섭, 김현옥. 국내 헌혈자 및 수혈 예정자의비예기항체빈도. 대한수혈학회지 2003;14: 160-72.).
5.Sung NH., Jeon TY., Lee EY., Chung JS., Cho GJ., Kim HH. Prevalence and specificity of unexpected antibody using antibody screening test including Dia and Mia cells. Korean J Lab Med. 2005. 25:340–6. (성낙현, 전태용, 이은엽, 정주섭, 조군제, 김형회. Dia와 Mia 항원을포함한적혈구 특이 항원에 대한 비예기항체 빈도 및 그 특성에 관한 연구. 대한진단검사의학회지 2005;25: 340-6.).
6.Park JR., Heo WB., Park SH., Park KS., Suh JS. The frequency unexpected antibodies at Kyungpook National University Hospital. Korean J Blood Transfus. 2007. 18:97–104. (박정란, 허운보, 박성화, 박관석, 서장수. 경북대학교병원에서 동정된 비예기항체의 빈도와 분포. 대한수혈학회지 2007;18: 97-104.).
7.Song DH., Moon IS., Hong SJ., Park JH., Kim JG., Jeon DS. Frequency and distribution of unexpected antibodies of Koreans. Korean J Blood Transfus. 1998. 9:191–200. (송달효, 문인석, 홍석주, 박재학, 김종규, 전동석. 한국인의비예기항체빈도와분포. 대한수혈학회지 1998;9: 191-200.).
8.Kim HO., Won DI., Kwon OH. The frequencies of unexpected antibodies in transfusion candidates and selection of cross-matching method. Korean J Blood Transfus. 1993. 4:3541. (김현옥, 원동일, 권오헌. 수혈대상환자의 불규칙항체 빈도 및 그 임상적 의의. 대한수혈학회지 1993;4: 35-41.).
9.Kim CW. A study on identified red cell irregular antibodies in Korea. Korean J Blood Transfus. 1994. 5:31–7. (김춘원. 한국인에서 검출된 불규칙항체에관한연구. 대한수혈학회지 1994;5: 31-7.).
10.Kim BS., Kim HO., Song KS., Lee SY. Frequency of irregular antibodies detected by type and screen procedure. Korean J Blood Transfus. 1990. 1:47–50. (김백수, 김현옥, 송경순, 이삼열‘. Type & Screen’법실시에따른불규칙항체검출빈도. 대한수혈학회지 1990;1: 47-50.).
11.Lee WH., Kim SY., Kim HO. The incidence of unexpected antibodies in transfusion candidates. Korean J Blood Transfus. 2000. 11:99–103. (이운형, 김신영, 김현옥. 수혈대상환자에서의비예기항체빈도. 대한수혈학회지 2000;11: 99-103.).
12.Brecher ME, editor. Technical Manual. 14th ed.Bethesda: American Association of Blood Banks;2002. p. 393–420.
13.Alves de Lima LM., Berthier ME., Sad WE., DiNapoli J., Johnson CL., Marsh WL. Characterization of an anti-Dia antibody causing hemolytic disease in a newborn infant. Transfusion. 1982. 22:246–7.
14.Lee SM., Im SJ., Park SE., Lee EY., Kim HH. A case of severe hemolytic disease of the newborn due to anti-Dia antibody. Korean J Lab Med. 2007. 27:373–6. (이선민, 임선주, 박수은, 이은엽, 김형회. 항-Dia에 의한중증신생아용혈성질환 1예. 대한진단검사의학회지 2007;27: 373-6.).
15.Fluit CR., Kunst VA., Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion. 1990. 30:532–5.
Article
16.Hoeltge GA., Domen RE., Rybicki LA., Schaffer PA. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med. 1995. 119:42–5.
17.Schonewille H., Haak HL., van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic disease. Transfusion. 1999. 39:763–71.